|
|
|
|

|
|
Back to list
|
|
Scabies |
|
Background:
Scabies is a common rash in the
pediatric population. It is caused by the
arthropod Sarcoptes scabiei. The mite is
transmitted via prolonged direct human contact and
rarely by fomites. The adult female mite is
0.3-0.5 mm long and has 4 pairs of legs. The term
scabies is believed to be derived from the Latin
term scabere, which means to scratch or
possibly from the scabs, which are
secondary to bacterial infection.
Pathophysiology:
The skin is the
main organ involved. The lesion is caused by the
gravid female mite burrowing beneath the stratum
corneum. She leaves behind a trail of debris, eggs
and feces (scybala), which induces an immunologic
response. The female can lay up to 90 eggs in her
30-day lifespan. It takes 3-4 days for the larvae
to hatch; they mature to adult forms over the next
2 weeks and continue the cycle. The average
patient is infected with 10-15 live adult female
mites at any given time.
Pruritus,
the main clinical manifestation, is caused by the
phenomenon of hypersensitivity to the debris, eggs
and feces, rather than by direct effects of the
mite. The primary lesions appear between 3-10 days
after exposure to the mite. These lesions include
burrows, papules, vesicles and pustules. The rash
usually becomes intensely pruritic several days
later as the immune system requires time to mount
a hypersensitive response. Nocturnal pruritus is
characteristic of scabies infestation.
Frequency:
- In the US:
Scabies may be seen in
all ages. It is not always a disease of
overcrowding. Norwegian (crusted) scabies is
seen in immunocompromised, HIV positive and
institutionalized patients.
Mortality/Morbidity:
Intense pruritus is
the major morbidity associated with scabies. This
often leads to excoriation and secondary bacterial
infection.
Race:
There appears to be no racial
predisposition to acquiring scabies.
Age:
Scabies can infect all age groups
from infancy to adulthood.
History:
- Main presenting features
include rash and intense itching.
- In young infants, pruritus
may be difficult to detect. Irritability,
especially during sleep, may be the only
symptom.
- History of involvement of
other family members and contacts is often
present and helps in establishing the diagnosis.
Physical:
- Primary and secondary lesions
- The classic rash of scabies
includes primary and secondary lesions.
- The primary lesions include
burrows, papules, vesicles and pustules.
- The secondary lesions occur
from scratching and include excoriated papules
and crusted areas.
- In infants, the most
commonly affected areas are the palms, soles,
axilla and scalp.
- Involvement of the face is
uncommon after 5 years of age.
- In older children and
adults, lesions are usually confined below the
neck and involve the web spaces between the
fingers, flexor surfaces of the arms, wrists,
axillae and the waistline. The umbilicus,
nipples, penis and scrotum may also be
affected.
- Norwegian (crusted) scabies
- Norwegian scabies is
characterized by crusted lesions and scaly
plaques located mainly on the hands, feet,
scalp and other pressure-bearing areas. These
may sometimes generalize. Hyperkeratosis may
occur in these lesions.
- Patients with Norwegian
scabies can be infected with hundreds to
millions of adult female mites. As a result,
this type of scabies is highly contagious and
may spread rapidly through patients in an
institutionalized setting.
- Orange-red nodules located
in the axillae and groin define nodular
scabies. These nodules are pathognomonic of
scabies infection.
Other Problems to be
Considered:
Canine scabies
Dermatitis herpetiformis
Drug reactions
Insect bites
Papular urticaria
Viral exanthem
Lab Studies:
- The diagnosis can often be
made on clinical grounds in patients with a
pruritic rash and characteristic linear burrows.
Definitive diagnosis of scabies is made by
direct visualization of the mite, eggs or feces.
Mineral oil should be placed on the end of a
burrow, preferably where a black dot is seen.
The area should then be scraped with a number 5
scalpel blade and the scrapings shed onto a
slide. The mite can be visualized under low
power microscopy. In infants and young children,
75% of mites can be found on the hands and feet
making this the best site to examine for a
burrow.
Histologic
Findings: The
female mite is 0.3-0.5 mm in length. She has a
tortoise-shaped body with 4 pairs of very short
legs, 2 pairs in front and 2 in back. The mite
also has bristles on its dorsal surface.
Medical Care:
The mainstay of treatment is
antiscabicidal medications. Appropriate
application and treatment of all contacts
including family members is the key to success.
Antipruritic measures and drugs should be used
only in conjunction with scabicidal medications.
Scabies is treated with topical
antiparasitic medications. The treatment of choice
is permethrin 5% lotion. Alternative drug therapy
includes precipitated sulfur in 6% petrolatum,
lindane, crotamiton and ivermectin. Topical
antibiotics may be used to treat secondarily
infected lesions. Compliance to the prescribed
regimen is essential to prevent reinfestation or
resistant scabies.
Drug Category: Scabicidal
agents -- Mechanisms of action include
depolarization and paralysis of the pests or
nervous system stimulation.
Drug Name
|
Permethrin
5% (Elimite, Nix) -- Permethrin is a
neurotoxin that causes paralysis and death in
ectoparasites. It is the most common treatment
used today for scabies. DOC, particularly for
infants, young children and pregnant or
breastfeeding women. The lotion should be
applied over the entire body, including the
face and scalp in infants. It should be left
on for 8-12 hours and then rinsed.
Reapplication one week later is advised;
however, there are no controlled studies
showing that 2 applications are better than
one. There have been no documented cases of
scabies resistant to permethrin. |
| Adult Dose |
Apply thin film topically over
entire body below the head, leave on 8-12 h
before washing off with water; may repeat in 1
wk if necessary |
| Pediatric
Dose |
Infants >2 months: Apply as in
adults and also on hairline, neck, scalp,
temple and forehead
Children: Apply as in adults if hair not
infested
|
|
Contraindications |
Documented hypersensitivity to
permethrin or chrysanthemums |
|
Interactions |
None reported |
| Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Treatment may temporarily
exacerbate the symptoms of itching, redness,
and swelling; do not use near eyes or in
mucous membranes |
Drug Name
|
Precipitated sulfur 6% in
petrolatum -- This is the oldest known
treatment of scabies. It is safe and effective
and the treatment of choice in infants under 2
months of age and pregnant or lactating women.
Sulfur is less acceptable to patients
secondary to its odor and messy application.
|
| Adult Dose |
Apply topically to entire trunk
and extremities hs for 3 consecutive nights
|
| Pediatric
Dose |
Apply as in adults (see
precautions) |
|
Contraindications |
Documented hypersensitivity to
sulfur or sulfonamides |
|
Interactions |
None reported |
| Pregnancy |
C - Safety for use during
pregnancy has not been established.
|
|
Precautions |
Caution if applied to irritated
or abraded skin,
<2 y (only when supervised by physician,
fatalities have been reported in infants after
application to large surface areas for
treatment of scabies); avoid contact with eyes |
Drug Name
|
Lindane
1% (gamma benzene hexachloride, Kwell) --
Previous standard treatment for scabies, but
it is not very safe in children due to
transcutaneous absorption leading to
neurotoxicity. Overall, permethrin is a safer
choice. |
|
Adult Dose |
Apply thin film topically over
entire body below the head, leave on 8-12 h
before washing off with water; may repeat in 1
wk if necessary; not to exceed 30
g/application |
|
Pediatric Dose |
Infants and children: Apply
thin film topically over entire body including
hairline, neck, scalp, temple and forehead,
leave on 6-8 h before washing off with water;
may repeat in 1 wk if necessary; not to exceed
30 g/application |
|
Contraindications |
Documented hypersensitivity;
neonates; acutely inflamed skin or raw,
weeping surfaces |
|
Interactions |
Oil-based hair dressing may
increase toxic potential |
|
Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Caution if history of seizures;
do not apply to eyes, face, or mucous
membranes; caution if history of
keratinization/ichthyosis disorders |
Drug Name
|
Crotamiton
10% (Eurax) -- Used for the treatment of
scabies. Mechanism of action is unknown.
Associated with frequent treatment failures.
|
| Adult Dose |
Wash thoroughly and scrub away
any loose scales, apply thin layer topically
from neck to toes, gently massage into skin
and leave on. A second application should be
applied after 24 h. Bathe 48 h after the last
application. |
| Pediatric
Dose |
Infants and children: Apply as
in adults |
|
Contraindications |
Known hypersensitivity
|
|
Interactions |
None reported |
| Pregnancy |
C - Safety for use during
pregnancy has not been established.
|
|
Precautions |
Treatment may temporarily
exacerbate the symptoms of itching, redness
and swelling; do not apply to face, urethral
meatus, eyes, mucous membranes or a swollen
skin |
Drug Name
|
Ivermectin
(Mectizan, Stromectol) -- Oral anthelmintic
agent that has been used extensively in
veterinary medicine. It is currently approved
for the treatment of human onchocerciasis, and
strongyloidiasis. It is not approved for the
treatment of scabies.
Binds selectively with glutamate-gated
chloride ion channels in invertebrate nerve
and muscle cells, causing cell death.
Half-life is 16 h; metabolized in liver. It
will kill the mites but will not affect the
eggs.
Ivermectin has been researched recently as an
oral treatment for scabies. A single dose
orally has also been found to be highly
efficacious in the treatment of scabies in HIV
infected patients. It is still in the early
stages of trial. |
| Adult Dose |
200 mcg/kg PO once; a repeated
dose may be necessary if the patient infected
with Norwegian scabies or immunocompromised
patients; redosing requires further evaluation
|
| Pediatric
Dose |
<15 kg: Not established
>15 kg: Administer as in adults
|
|
Contraindications |
Documented hypersensitivity
|
|
Interactions |
May interact with other ligand-gated
chloride channels, such as those gated by GABA
|
| Pregnancy |
C - Safety for use during
pregnancy has not been established.
|
|
Precautions |
Caution in breastfeeding women;
may cause nausea, vomiting, drowsiness or mild
CNS depression; patients with hyperreactive
onchodermatitis may develop a severe immune
reaction (ie, Mazzotti reaction) consisting of
optic neuritis, chorioretinitis, proteinuria,
pruritus, rash and edema |
Drug Category: Topical
Antibiotics -- Used to treat lesions with
secondary infection.
Drug Name
|
Mupirocin
(Bactroban) -- Used to treat
Staphylococcus species, beta-hemolytic
streptococci and S pyogenes. It
inhibits protein and RNA synthesis by
inactivating transfer-RNA synthetase.
|
| Adult Dose |
Apply a small amount topically
to the affected areas 2-5 times daily for 5-14
d |
| Pediatric
Dose |
Apply as in adults |
|
Contraindications |
Known hypersensitivity
|
|
Interactions |
None reported |
| Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Prolonged use may result in
overgrowth of nonsusceptible organisms; do not
compound with Aquaphor, coal tar solution, or
salicylic acid |
Drug Category: Topical
corticosteroids -- May be applied to help
control intense pruritus caused by scabies.
Drug Name
|
Hydrocortisone - topical
(Cortaid, Dermacort, Westcort, CortaGel) -- An
adrenocorticosteroid derivative suitable for
application to skin or external mucous
membranes. It has mineralocorticoid and
glucocorticoid effects resulting in
anti-inflammatory activity. Considered to be
the lowest potency topical steroid.
|
| Adult Dose |
Apply topically to affected
areas sparingly tid/qid |
| Pediatric
Dose |
Apply as in adults |
|
Contraindications |
Documented hypersensitivity;
viral, fungal, and bacterial skin infections
|
|
Interactions |
None reported |
| Pregnancy |
C - Safety for use during
pregnancy has not been established.
|
|
Precautions |
Prolonged use, applying over
large surface areas, application of potent
steroids, and occlusive dressings may increase
systemic absorption and may cause Cushing's
syndrome, reversible HPA-axis suppression,
hyperglycemia, thinning of skin, or glycosuria |
Further Inpatient Care:
- Patients may need to be
reexamined at 2 weeks and again one month after
treatment. Persistent pruritus after treatment
does not necessarily reflect treatment failure.
Hypersensitivity reaction may outlast the
presence of live parasites. Antihistamines and
topical corticosteroids may be used to control
pruritus until symptoms resolve. If a patient
has persistent lesions at the one month
check-up, reinfection or persistent infection
should be suspected. In this case, treatment
should be reinitiated. The family or any close
contacts should also be examined to check for a
source of reinfection.
Further Outpatient Care:
- All family members and close
contacts should be treated even if asymptomatic
to prevent reinfection. All bed linen and
clothing should be washed in order to remove
eggs and mites. Fomites can exist for 2-3 days
without a host. Articles that cannot be washed
should be kept in sealable plastic bags for 3
days.
Complications:
- Secondary lesions may occur
from scratching and include excoriated papules
and crusted areas. These lesions may become
secondarily infected. Topical antibiotics can be
used to treat minor superinfection, and oral
antibiotics may be required for more extensive
infection. The most common infectious agents are
skin flora including Staphylococcus spp. and
Streptococcus spp.
Prognosis:
- Scabies has an excellent
prognosis. If one medication fails, multiple
treatments with scabicides or sequential use of
several agents can be curative.
Patient Education:
- Education is extremely
important. The mode of transmission is via human
contact as well as fomites. All close contacts
must be treated or reinfection will occur.
|
|
Back to list
|
|
|